Communiqués Inovio Pharmaceuticals, Inc.

Actions

INO

US45773H4092

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX 17:44:53 02/10/2026			Varia. 5j.	Varia. 1 janv.
1,195 ^USD	-1,24%		0,00%	-32,18%

11/09	Transcript : Inovio Pharmaceuticals, Inc. Presents at H.C. Wainwright 28th Annual Global Investment Conference, Sep-11-2026 07:00 AM
10/09	Transcript : Inovio Pharmaceuticals, Inc. Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference, Sep-09-2026 03:20 PM

Communiqués

01/09	INOVIO to Participate in Upcoming Investor Conferences	PR
12/08	Inovio: Q2 Earnings Snapshot	AQ
12/08	INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights	PR
04/08	INOVIO to Report Second Quarter Financial Results on August 12, 2026	PR
30/07	INOVIO Announces Pricing of $20.0 Million Public Offering	PR
29/07	INOVIO Announces Proposed Public Offering	PR
01/06	Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm	NE
28/05	INOVIO to Participate in Upcoming Scientific and Investor Conferences	PR
21/05	Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China	PR
13/05	Inovio Pharmaceuticals : First Quarter 2026 Financial Results Conference Call Q1 2026 Financial Results Presentation	PU
13/05	Inovio: Q1 Earnings Snapshot	AQ
13/05	INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights	PR
08/05	INOVIO to Participate in Upcoming Scientific Conferences	PR
01/05	INOVIO to Report First Quarter Financial Results on May 13, 2026	PR
22/04	Inovio Pharmaceuticals : Combined Otolaryngology Spring Meetings (COSM) Abstract	PU
06/04	INO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026	NE
05/04	INO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026	NE
02/04	INOVIO Announces Pricing of $17.5 Million Public Offering	PR
02/04	INOVIO Announces Proposed Public Offering	PR
01/04	INOVIO to Participate in Upcoming Scientific Conference	PR
01/04	Inovio Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 7, 2026 to Discuss Your Rights - INO	PR
31/03	INO CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026	NE
29/03	INO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026	PR
27/03	INO Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026	NE
25/03	INO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026	NE